Comparison of nishakatkadi ghan vati with oral hypoglycemic agent in the treatment of diabetes mellitus
Phase 1
- Conditions
- Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
- Registration Number
- CTRI/2020/03/024195
- Lead Sponsor
- Principal PDEAs college of Ayurved and Research centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Age group between 35 years to 70 years
2.cases of both gender will be included
3.patient with fasting blood sugar upto 200 mg% and post parandial blood sugar 300mg%
Exclusion Criteria
1.insulin dependent diabetes mellitus (IDDM)and those who are under insulin therapy.
2.patient with acute complications like hyperglycemic and hypoglycemic coma,ketoacidosis and related complication and infections like gangrene.
3.patient with chronic diabetic complications like Nephropathy,Neuropathy and Retinopathy.
4.pregnant and lactating woman.
5.patients suffering from all major systemic diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate efficacy of Nishakatkadi Ghan Vati 500mg three times before breakfast,lunch and dinner a day for 3 months as an adjuvant medication to oral hypoglycemic agent in the management of diabetes mellitus type 2on basis of BSL and HbA1C valuesTimepoint: 90 Days with follow up on every 15th day
- Secondary Outcome Measures
Name Time Method 1.to study the effect of Nishakatkadi Ghan vati 90days. <br/ ><br>2.to study the effect of oral Hypoglyacemic agent. <br/ ><br>3.to observe the adverse effect if anyTimepoint: 90 days